logo

For the Inventor, By the Inventor

Crox, France

Stéphane Burlet

This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Alzprotect, National Institute of Health and Medical Research, Université De Lille 2 Droit Et Santé. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stéphane Burlet. Retrieved from https://idiyas.com/inventor/stéphane-burlet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Croix, FR (2017)
  • Crox, FR (2020)

Company Filing History:

goldMedal4 out of 6 
 
Alzprotect
 patents
silverMedal2 out of 1,853 
 
National Institute of Health and Medical Research
 patents
bronzeMedal1 out of 13 
 
Université De Lille 2 Droit Et Santé
 patents
4. 1 out of 1 
 
Universite De Lille 2 Droit Et Saute
 patent
where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 12790305 - Succinate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H- benzo[d]imidazol-2-amine, preparation thereof and use of the same (2026-11-10),
2. 10772884 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-09-15),
3. 10537569 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-01-21),
4. 9562018 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2017-02-07),

Title: Stéphane Burlet: Innovator in Neurodegenerative Disease Treatment

Introduction

Stéphane Burlet is a notable inventor based in Crox, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of neurodegenerative diseases. With a total of 4 patents to his name, Burlet's work is recognized for its innovative approach to complex medical challenges.

Latest Patents

Stéphane Burlet's latest patents focus on sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine. These patents detail the preparation and use of these compounds, which are essential in developing pharmaceutical compositions aimed at treating neurodegenerative diseases. The inventions highlight the importance of these sulphate salts and their pharmaceutically acceptable solvates in advancing medical treatments.

Career Highlights

Throughout his career, Stéphane Burlet has worked with prominent organizations such as Alzprotect and the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale). His experience in these institutions has allowed him to contribute significantly to research and development in the pharmaceutical sector.

Collaborations

Stéphane Burlet has collaborated with various professionals in his field, including Cécilia Estrella and Mathieu Barrier. These partnerships have fostered innovation and have been instrumental in the advancement of his research.

Conclusion

Stéphane Burlet's contributions to the field of pharmaceuticals, particularly in neurodegenerative disease treatment, underscore his role as an influential inventor. His patents and collaborations reflect a commitment to improving healthcare through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…